Registry study of Globe pulsed field ablation for atrial fibrillation
Part of Heart & circulation clinical trials.
This study follows patients who are already scheduled to receive a specific heart rhythm treatment called Globe pulsed field ablation for atrial fibrillation (an irregular heartbeat condition). Researchers will track how well the procedure works and how patients do afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already have an appointment scheduled for Globe pulsed field ablation treatment
- You must not have a condition that prevents you from having this type of heart catheter procedure
- You must be expected to live at least 1 year from now
- You cannot currently be enrolled in another investigational medical device or drug study (unless already approved)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial is a registry that tracks patients who have had a second pulsed-field ablation (PFA) procedure for atrial fibrillation after a first PFA treatment. The goal is to learn more about how safe and effective these repeat procedures are.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.